Dispatch Energy Acquires Green Lantern Solar (GLS), Extending its Distributed Generation Footprint Across Nine States The acquisition includes 64 projects, totalling 208.9 MWdc, which strengthens Dispatch's position in the solar generation market and expands Dispatch's operations and maintenance services GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Dispatch Energy LLC (“Dispatch”), […]

Bunzl Canada Earns 2025 Great Place to Work(R) Certification Employee Trust Index affirms commitment to a thriving, inclusive workplace culture GlobeNewswire November 12, 2025 Bunzl Canada's annual Delivery & Warehouse Appreciation Week recognizes the dedication of drivers and warehouse teams, fostering a culture of respect, pride, and trust that supports its Great Place To Work(R)

Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference GlobeNewswire November 12, 2025 BOSTON, Nov. 12, 2025 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Jefferies Global Healthcare

SEED Therapeutics Receives IND Clearance from China's NMPA for ST-01156 China Sites to Join Upcoming Global Expansion Study Evaluating RBM39-Dependent Cancers GlobeNewswire November 12, 2025 KING OF PRUSSIA, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) — SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rational molecular glue degraders for historically undruggable disease drivers, today announced

Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Psyence BioMed (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that, through its strategic investment in

TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 12, 2025 Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meeting Data from ALLOHA(TM) Phase 1 heme trial to be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition

High Roller Announces Appointment of Jake Francis as Chief Operating Officer GlobeNewswire November 12, 2025 Las Vegas, Nevada, Nov. 12, 2025 (GLOBE NEWSWIRE) — High Roller Technologies (“High Roller” and the “Company”) (NYSE: ROLR), operator of the award-winning, premium online casino brands High Roller, Fruta, and Kassuuu, today announced the appointment of Jake Francis as

Transom Acquires Binswanger Glass, Accelerating Next Phase of Growth for Leading U.S. Glazing Company Acquisition brings new investment and operational resources to fuel Binswanger Glass's expansion and service excellence, building on its 150-year legacy GlobeNewswire November 12, 2025 LOS ANGELES, Nov. 12, 2025 (GLOBE NEWSWIRE) — Transom Capital Group (“Transom”), a Los Angeles-based private equity

Climb Channel Solutions Announces Strategic Partnership with Liongard GlobeNewswire November 12, 2025 EATONTOWN, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is excited to announce a strategic partnership with Liongard, a leader in asset intelligence and automation.

Destination XL Group, Inc. to Announce Third Quarter 2025 Financial Results on Thursday, December 4, 2025 Company to Webcast Conference Call Live at 9:00 a.m. ET GlobeNewswire November 12, 2025 CANTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men's clothing